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Background: Protein cross-coupling reactions demand high yields, especially if the products are intended for
bioanalytics, like enzyme-linked immunosorbent assays. Amongst other factors, the coupling yield depends on the
concentration of the proteins being used for coupling. Protein supercharging of enzymes can increase the
solubility dramatically, which could promote enzyme-antibody coupling reactions. A highly soluble, supercharged
variant of the enzyme human enteropeptidase light chain was created by a site-directed mutagenesis of surface
amino acids, used for the production of an antibody-enzyme conjugate and compared to the wild type enzyme.
Results: Wild type and mutant enzyme could successfully be cross-coupled to an antibody to give
antibody-enzyme conjugates suitable for ELISA. Their assay performances and the analysis of the enzyme activities
in solution demonstrate that the supercharged version could be coupled to a higher extent, which resulted in
better assay sensitivities. The generated conjugate, based on the supercharged enzyme, was feasible as a reporter
molecule in a sandwich ELISA and allowed the detection of epidermal growth factor with a detection limit of
15.63 pg (25 pmol/L).
Conclusion: The highly soluble, surface supercharged, human enteropeptidase light chain mutant provided better
yields in coupling the enzyme to an antibody than the wild type. This is most likely related to the higher protein
concentration during the coupling. The data suggest that supercharging can be applied favourably to other
proteins which have to be covalently linked to other polymers or surfaces with high yields without losses in
enzyme activity or specificity.
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The extraordinary feature of enzymes to catalyze reac-
tions with a high selectivity is utilized in a broad field of
applications, including the paper-, food- and pharma-
ceutical industry [1]. Besides this, enzymes are used as
bioanalytical tools, such as in biosensors or as amplifying
agents in immunoassays. One prominent application is
the enzyme-linked immunosorbent assay (ELISA), where
an antibody-enzyme conjugate is used for the detection
and quantification of analytes. Due to its compatibility
to complex samples, this approach became a method of
high significance in routine analysis and research [2].* Correspondence: Thole.Zuechner@octapharma.com
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unless otherwise stated.Most applications have in common, that the enzyme has
to be immobilized. Whilst adsorption, entrapment and
covalent-cross coupling procedures are feasible for con-
tinuous flow-through processes in industry [3], the latter
is essential for the production of ELISA conjugates. The
application in this type of immunoassay requires a syn-
thesis protocol which ideally results in a conjugate with
an enzyme:antibody ratio of at least 1:1, without causing
side-products and, more importantly, remaining uncon-
jugated antibody [4].
Different coupling strategies have been developed, espe-
cially for the popular reporter enzymes horseradish perox-
idase, alkaline phosphatase and β-galactosidase. The
coupling reaction for the first enzyme-antibody conjugate
applied in ELISA was based on the homobifunctional linker
glutaraldehyde [5,6]. Although the resulting enzyme-
protein complex partially retains its enzymatic activity and
immunological specificity, it suffers from the formation oftd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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bifunctional linker molecules have been developed, which
can react to two different functional groups, such as
amino groups, cis-hydroxyl-groups in carbohydrates and
thiol groups. As the coupling efficiency is also dependent
on the amount of coupling sites on the proteins [7], the
modification should occur to a large extend. Additionally,
high concentrations of proteins will result in higher yields
of coupling product, since diffusion- and orientation-
controlled ligation processes become more likely. Al-
though the commonly used enzymes in ELISA allow a
satisfactory performance for most applications, the adop-
tion of other enzymes might be interesting in terms of
substrate diversity and sensitivity.
In 2007, Lawrence et al. presented a method to decrease
protein aggregation tendencies by specific mutations of res-
idues on protein surfaces. This specific replacement of sur-
face amino acids with either acidic or basic amino acids
was termed supercharging, as the net charge of the mutants
were more positive or negative [8]. Supercharged proteins
have been engineered to overcome limitations of macro-
molecule delivery into mammalian cells [9] and to increase
thermal stability of antibody fragments [10]. This strategy
might also be useful to improve the yield of protein-protein
coupling reactions, especially the linking of enzymes to
antibodies for immunological applications.
We adapted supercharging to the light chain of the hu-
man enteropeptidase in an earlier study and the resulting
mutant, hEPl scC112S (N6D, G21D, G22D, C112S, N141D,
K209E), showed a superior solubility and heat stability [11].
Here, we investigated the impact of enzyme supercharging
on chemical crosslinking as exemplified for an antibody-
enzyme conjugate. Therefore, hEPl scC112S and its wild
type variant (hEPl wt) were conjugated to a secondary




Enzymes (hEPl wt and hEPl scC112S) were expressed,
refolded and purified in-house [11]. Polyclonal
sheep-anti-mouse and donkey-anti-rabbit antibodies
were from Dianova (Hamburg, Germany), monoclonal
mouse-anti-EGF, EGF protein and polyclonal rabbit-
anti-EGF were from Abcam (Cambridge, UK). Citric
acid and Tween®20 were from Serva Electrophoresis
(Heidelberg, Germany), Tris(hydroxymethyl)-amino-
methan was from Applichem (Darmstadt, Germany).
C6-Succinimidyl-4-formylbenzoate and C6-Succinimi-
dyl-4-hydrazinonicotinate acetone hydrazone were from
Acris Antibodies (Herford, Germany). Sodium chloride,
hydrochlorid acid (conc.), Na2HPO4x12H2O, KH2PO4,
GD4K-na and DMSO were purchased from Sigma-
Aldrich (Taufkirchen, Germany) in the highest puritiesavailable. Roti®-Block was ordered from Roth (Karlsruhe,
Germany). Bovine serum albumin standard was from
Thermo Fisher Scientific (Rockford, USA). Deionized water
was obtained from a Purelab Ultra water purification sys-
tem (ELGA LabWater, Celle, Germany; 18.2 MΩ*cm).
Antibody-enzyme coupling
A 1.5-fold molar excess of enzyme (hEPl wt: 90 μg/mL or
hEPl scC112S: 440 μg/mL) was coupled to a sheep-anti-
mouse antibody (2.4 g/L) after dialysing the proteins against
modification buffer (0.1 mol/L phosphate buffer, 0.15 mol/L
NaCl, pH 8.0) separately for 16 hours at 4°C using a 12 kDa
cut-off dialysis tube (Sigma-Aldrich). Afterwards, the anti-
body was mixed with 40 equivalents of C6-succinimidyl-4-
formylbenzoate (9 g/L in DMF), while enzymes have been
modified with 40 equivalents of C6-succinimidyl-4-hydrazi-
nonicotinate acetone hydrazone (5.2 g/L in DMF). The reac-
tion mixtures were incubated at room temperature for
3 hours and excess linker molecules were removed by dialy-
sis against conjugation buffer (0.1 mol/L citric acid,
0.15 mol/L NaCl, pH 6.0) at 4°C. Antibody and enzyme
solution were mixed and incubated at 4°C. After 20 hours,
protein concentrations were determined using a Bradford
assay according to standard protocols with bovine serum al-
bumin as standard [12]. The solutions were used without
further treatment.
The ELISA-conjugate was obtained by increasing the
concentration of hEPl scC112S from 0.242 g/L to 3.6 g/L
by lyophilisation from 5 mmol/L Tris-buffer (pH 8.0) and
subsequent resolubilization of the enzyme in water. Coup-
ling was performed as described above, using a donkey-
anti-rabbit antibody (1.2 g/L) and a 10-fold molar excess of
enzyme.
Enzyme assay
Kinetic characterization of the enzymes was performed in
a 0.1 mol/L Tris–HCl buffer (pH 8.0, 10% DMSO) at
room temperature using black 384-well plates (non-bind-
ing, Greiner Bio-one, Frickenhausen, Germany). GD4K-na
in concentrations varying from 3.7 to 947 μmol/L was
cleaved by addition of hEPl wt and hEPl scC112S (final
concentration 10 nmol/L). The linear increase of released
2-naphthylamine was recorded on a Paradigm fluores-
cence reader (Molecular Devices, Ismaning, Germany)
using a fluorescence cartridge (λex = 360/35 nm; λem =
465/35 nm; integration time 140 ms). All experiments
were performed in triplicates.
Enzyme-linked immunosorbent assay (ELISA)
ELISA experiments were performed in black 384-well micro-
titre plates (high-binding, Greiner Bio-one, Frickenhausen,
Germany) with an assay volume of 100 μL. All experiments
were performed in triplicates.
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coupling with 1.5 equivalents hEPl wt or hEPl scC112S
was determined using an affinity test. 100 μL of an in-
house produced monoclonal antibody (HPT-104 [13],
2.25 μg/mL) were incubated at 4°C for 16 hours. After a
threefold washing step using 200 μL washing buffer
(phosphate buffered saline, 10 mmol/L phosphate,
0.3 mol/L NaCl, pH 7.4, 0.05% (v/v) Tween®20), free
binding sites were blocked with 120 μL blocking buffer
(0.5% (w/v) casein in washing buffer). After a further
washing step, conjugate solutions were added with a
total protein concentration of 2 μg/mL and incubated.
After removal of unbound components by washing, sig-
nals were generated by addition of 50 μmol/L GD4K-na
in assay buffer (0.1 mol/L Tris–HCl, pH 8.0, 10%
DMSO) and the fluorescence was monitored at 465 nm
after excitation at 360 nm.
The microtitre plate for the EGF sandwich ELISA was
coated with monoclonal mouse-anti-EGF antibody by incu-
bating the solution (100 μL, 1 mg/L) at 4°C for 16 hours.
After washing, blocking was performed with 120 μL Roti®-
Block and the plate was washed again before the addition of
a four-fold serial dilution of EGF (10 ng/mL to 39.1 pg/mL)
in E. coli cell lysate (protein concentration 6 mg/L). After in-
cubation for 1 hour and washing, 100 μL of a polyclonal
rabbit-anti-EGF antibody (250 ng/mL) was added. Subse-
quently, the plate was washed and 100 μL of the diluted
(1:1000) antibody-enzyme conjugate was incubated for
one hour. After washing, 50 μmol/L GD4K-na (in 0.1
mol/L Tris–HCl, pH 8.0, 10% DMSO) was added for
signal development. End-point measurement was per-
formed 4 hours after incubation at 37°C with λex =
360 nm and λem = 465 nm. All experiments were per-
formed in triplicates.
Results
Low reaction volumes are favoured for antibody-enzyme
coupling reactions to obtain high coupling yields. Hence,
proteins with high solubility are favoured for coupling.
We therefore investigated, if the method of protein
supercharging can produce mutants that are more suit-
able for coupling reactions compared to their wild type
enzymes using human enteropeptidase light chain (hEPl)
as a model enzyme (Figure 1). The light chain of
the enteropeptidase holoenzyme, a 26 kDa enzyme-
fragment, contains the catalytic triade and is therefore
sufficient for most enzymatic applications. In an earlier
study, a rational design of a mutant with a high surface
charge (N6D, G21D, G22D, C112S, N141D, K209E) re-
sulted in a more than 100-fold increase in enzyme solu-
bility [11], which should affect the coupling reaction
positively.
As a first step for the characterization of the enzyme,
the kinetic parameters of the wild type and mutatedenzyme were determined (Table 1 and Additional file 1).
GD4K-na was chosen as a specific substrate, because its
cleavage can be detected with high sensitivity (λex =
360 nm, λem = 465 nm). The data indicate that the mu-
tation of the enzyme resulted in a slightly decreased
affinity towards the substrate, as the Michaelis constant
Km was increased from 0.11 mmol/L (hEPl wt) to
0.65 mmol/L for hEPl scC112S. The insertion of aspartic
acid and glutamic acid in the mutant decreased the net
charge of the enzyme by a difference of 6. This could re-
sult in electrostatic repulsion between enzyme surface
and the tetra-aspartyl-motif of the substrate, and could
be an explanation for the slightly lower substrate affinity
of the supercharged enzyme hEPl scC112S. On the other
hand, the mutant enzyme possesses an increased turn-
over number for GD4K-na, which confirms the data ob-
tained in earlier studies for another substrate, Z-Lys-
SBzl [11]. This means that at high concentrations of sub-
strate (>1 mmol/L), the mutated variant hEPl scC112S
would result in a faster signal increase upon digestion
than the wild type enzyme.
In order to analyze the coupling efficiencies of the two
enzymes, both enzymes were coupled to a secondary
antibody under the same coupling conditions and an
ELISA experiment was carried out. Both enzyme conju-
gates led to signals that differed distinctly from the nega-
tive control. The signal increase for the supercharged
conjugate (Ab-hEPl scC112S) was significantly higher
than that for the wild type conjugate (Ab-hEPl wt)
(Figure 2). While Ab-hEPl scC112S induced a signal in-
crease of 15758 fluorescence intensity units per minute,
application of the wild type conjugate resulted in a signal
increase of only 2611 fluorescence intensity units per
minute.
This indicates a higher yield of supercharged enzyme-
antibody conjugate. Control experiments without anti-
gen did not show any signal differing from the negative
control (Additional file 2). As the used substrate concen-
tration for the ELISA experiment in this study is much
lower (50 μmol/L) than the concentration needed to
reach vmax (1 mmol/L), the faster cleavage in the ELISA
obtained here can only origin from a higher amount of
enzyme-antibody conjugates.
This demonstrates that the application of enzyme
supercharging generated a highly soluble mutant, which
is more suitable for coupling processes than its wild type
form. Unfortunately, we were not able to further confirm
this result via native or denaturing SDS-PAGE or Western
Blot. Both methods did not show clear bands that could be
used for a quantification of the coupling product (data not
shown).
To further investigate possible bioanalytical applica-
tions of the synthesized conjugate, a coupling reaction
with a 10-fold molar excess of enzyme (hEPl scC112S)
Table 1 Kinetic parameters for the digestion of GD4K-na by hEPl wt and hEPl scC112S
Enteropeptidase Km [mmol/L] kcat [s
−1] kcat/Km [(mmol/L)
−1 s−1] Ref.
hEPl wt 0.11 ± 0.01 81.9 ± 9.8 745 This study
hEPl scC112S 0.65 ± 0.09 169.3 ± 24.5 260 This study






















Figure 1 Schematic principle of the improvement of a protein-protein coupling reaction by enzyme surface supercharging. A high
volume of wild type enzyme of the human enteropeptidase light chain is required due to its low solubility, resulting in a high total reaction
volume and low yield of coupling product (A). Highly soluble surface supercharged human enteropeptidase light chain permits an increase of
the enzyme concentration prior to the coupling process (B). Therefore the total reaction volume can be reduced to give a higher yield of desired
product (antibody-enzyme conjugate).

































Figure 2 Assay performances of hEPl wt and hEPl scC112S
conjugate solutions. Detection of an immobilized model antigen
(HPT-104 antibody [13]) was performed using 2 μg/mL total protein
of untreated conjugate solution. After incubation and washing,
signal was generated by addition of 50 μmol/L GD4K-na and























Epidermal Growth Factor [pg]
Figure 3 Use of a hEPl scC112S-antibody conjugate for the
detection of EGF. Epidermal growth factor (in E. coli cell lysate as
matrix) was detected using a sandwich ELISA and an in-house produced
donkey-anti-rabbit/hEPl scC112S conjugate as secondary antibody. Signal
was generated by addition of 50 μmol/L GD4K-na and an end-point
measurement was performed after 4 hours of incubation at 37°C. The
limit of detection (S/B >3xSD) was 15.63 pg EGF. Errors = SD, n = 3.
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porter molecule for the detection of epidermal growth
factor (EGF). EGF is a low-molecular-weight polypeptide
which affects many biochemical pathways by binding to
its receptor and can be used as a cancer biomarker [15].
EGF was diluted in a complex mixture (E. coli cell lysate,
6 mg/L) and detected in a standard sandwich ELISA
using two specific antibodies and the synthesized anti-
body conjugate (Ab-hEPl scC112S) was added for detec-
tion. The observed signals after addition of the peptide
substrate GD4K-na were dependent on the amount of
analyte present and permitted a detection of EGF down
to 15.6 pg (Figure 3). This indicates that the hEPl
scC112S mutant can be used as a reporter molecule in
ELISA, while the wild type enzyme is not suitable for
this application. This originates from the low solubility
of the wild type which does not allow a high-yielding
coupling protocol. In contrast to this, the supercharging
surface modification of the enzyme results in an
increased protein solubility as well as heat stability,
which subsequently lead to higher yields of the desired
antibody-enzyme conjugate.
Discussion
Enzymes, like the serine protease enteropeptidase examined
in this study, are widely used tools in biotechnology, indus-
try and bioanalytics due to their catalytic function and their
high specificity. However, many applications require the
immobilization of these proteins on insoluble surfaces
or on other biomolecules, such as other proteins. A very
prominent example for enzyme-protein couplings are
enzyme-antibody couplings and their subsequent use in
enzyme immunoassays. As discussed earlier, variousmethods for enzyme-antibody couplings exist. However,
the central problem of unsatisfactory protein solubility
affects all of those coupling methods in a negative way.
One way to improve protein solubility is to optimize
the buffer components of the coupling buffer by apply-
ing different ionic compounds or osmolytic stabilizers
like sugars and polymers [16]. However, proteins are
very sensitive to these conditions and slight modifica-
tions can cause protein precipitation, a loss in enzyme
activity or antibody affinity. Other methods for the im-
provement of protein solubility exist, though they are
not always suitable for the described problem. In 2009
Golovanov et al. showed, that protein solubility can be
increased by a simple addition of charged amino acids.
Addition of arginine and glutamic acid made several
proteins accessible to NMR-studies by suppression of
their aggregation tendencies [17]. Nevertheless, this
method may not be suitable for protein-protein coupling
reactions, since the additives possess the same reactive
moieties as the proteins (e.g. amino groups). In case of
protein modification with commonly used NHS-ester
based linker molecules, linker reactivity would be
quenched, as the reaction cannot occur specifically with
the protein. This would decrease the protein modifica-
tion degree and impact the overall coupling process
negatively.
Also the introduction of a solubility-enhancement tag, as
described in Lee et al. [18] and Zhou et al. [19] may have
undesired effects, because it might alter the enzyme’s activ-
ity and selectivity. In principle, a mutation of surface amino
acids of proteins can of course also lead to undesired side-
effects. However, a careful design of suitable amino acids
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us before for the mutation of surface amino acids of the hu-
man enteropeptidase light chain by site-directed mutagen-
esis [11].
Site-directed mutagenesis was found not only to be a tool
for tailoring enzyme activity and stability, but also to im-
prove immobilization reactions. Methods were reviewed in
detail before and are for example based on the production
of mutants that were capable of site-directed immobilization
via specific tags [20,21]. Such methods include the incorpor-
ation of particular amino acid sequences for affinity fixation
(anti-tag antibody to tagged enzyme, avidin to biotinylated
protein) or the addition of a Lys-containing tags for the co-
valent linkage via transglutaminase cross-coupling.
Coupling procedures for the synthesis of antibody-
enzyme conjugates require particularly high yields, since
any unlabeled antibody fraction decreases the assay sen-
sitivity, especially because it is difficult to purify the
resulting coupling product from unmodified antibody.
In addition to that, the preparation of highly pure and
active enzymes is enormously laborious, which makes
them an expensive material. Therefore high coupling
yields are desired not only in terms of assay perform-
ance, but also with regard to material costs.
In this study, we were able to demonstrate that site-
directed mutagenesis can be used to optimize coupling
reactions due to an enhancement of the protein solubil-
ity. For that purpose, we tested the potential of a super-
charged version of human enteropeptidase light chain
with respect to its antibody-coupling yield and could
show that the method of supercharging can evolve highly
soluble proteins that are suitable for coupling reactions. As
proven by us earlier, the site-directed surface modification
of the human enteropeptidase light chain resulted in a
more than 100-fold increased solubility which allowed the
use of a highly concentrated enzyme solution without caus-
ing protein aggregation. This allowed the covalent linkage
to an antibody with significantly higher yields compared to
the wild type enzyme. Lee and coworkers demonstrated
earlier that the resulting enteropeptidase-antibody conju-
gates are attractive components for heterogeneous immu-
noassays [22]. With the new coupling strategy, we showed
here that the medium-scale synthesis of this kind of
enzyme-antibody conjugates is possible, if a highly soluble
supercharged version of the enzyme is used.
In summary, we could show that the supercharged hu-
man enteropeptidase light chain can be effectively used
for the production of an antibody-enzyme conjugate.
This procedure allows the use of the mutant enzyme as
a reporter molecule in a sensitive ELISA system, while
the wild type enzyme failed for this application. We fur-
thermore suggest that this strategy can in principle be
used for the coupling of any desired enzyme to other
proteins. Examples of such enzymes which may be usedfor establishing novel ELISA systems may include subtil-
isin [23], acetylcholinesterase [24] and lipase [25].
Conclusion
This study showed that surface supercharging of proteins is
a suitable method for the improvement of protein-protein
cross coupling reactions. Hence, the biotechnologically im-
proved, highly soluble mutant hEPl scC112S could be uti-
lized as a reporter molecule for a sensitive ELISA system.
In contrast, the wild type enzyme could not be coupled to a
satisfactory extend and is therefore not suitable for this
application.
Additional files
Additional file 1: Characterization of enzyme kinetics for hEPl wt
and hEPl scC112S. Measurements were performed in 0.1 mol/L
Tris-buffer (pH 8.0, 10% DMSO) with a GD4K-na substrate concentration
range from 3.7 to 947 μmol/L. Enzymes were added to a final
concentration of 10 nmol/L and fluorescence was recorded at 465 nm
(λex = 360 nm). Km values were obtained from the fitted curves and were
0.11 mmol/L for hEPl wt and 0.65 mmol/L for hEPl scC112S. Errors = SD,
n = 3.
Additional file 2: Negative controls in ELISA. In the absence of
antigen, no unspecific binding by both conjugate mixtures could be
detected. Conjugate solutions with a total protein concentration of 2 μg/
mL were used; signal development was carried out by addition of
50 μmol/L GD4K-na. Errors = SD, n = 3.
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